AI Science Tracker
EN

FISM: harnessing deep learning and reinforcement learning for precision detection of microaneurysms and retinal exudates for early diabetic retinopathy diagnosis.

Department of Computer Science and Technology, University of Science and Technology of China, Hefei, 230026, China · 30 Oct 2025 · medicine

Discovery

FISM: harnessing deep learning and reinforcement learning for precision detection of microaneurysms and retinal exudates for early diabetic retinopathy diagnosis.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: The source evaluates lesion segmentation/classification with accuracy, precision, recall, IoU and ROC analyses.

Technology: FISM combines deep-learning lesion segmentation and reinforcement-learning detection for diabetic-retinopathy lesions.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
FISM combines deep-learning lesion segmentation and reinforcement-learning detection for diabetic-retinopathy lesions.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/41168809 · https://pmc.ncbi.nlm.nih.gov/articles/PMC12576988/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.